|
Peter Libby
|
9
|
Resverlogix Corp.
|
Aug 14, 2019 09:31AM
|
|
Re: What else can RVX treat that we don’t know about yet?
|
7
|
Resverlogix Corp.
|
Mar 30, 2019 09:44PM
|
|
Peter Libby / You Tube Interview
|
6
|
Resverlogix Corp.
|
Aug 16, 2019 07:59AM
|
|
Re: RVX closes PP...getting US money in?
|
6
|
Resverlogix Corp.
|
Nov 02, 2018 04:34PM
|
|
Re: BET proteins, NFkB and Diabetic Kidney Disease
|
6
|
Resverlogix Corp.
|
Nov 05, 2018 04:48PM
|
|
Re: Losing exclusivity on Aberatirone may not be all that bad for JNJ or ZEL
|
6
|
Zenith Epigenetics
|
Nov 22, 2018 01:42PM
|
|
ZE Slides Up
|
6
|
Zenith Epigenetics
|
Jan 08, 2019 03:58PM
|
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
6
|
Resverlogix Corp.
|
Jan 30, 2019 01:30PM
|
|
Market Pricing
|
6
|
Resverlogix Corp.
|
Jun 12, 2019 04:41PM
|
|
Re: Antibodies Against Microglial Receptors TREM2 and CD33 Head to Trials
|
6
|
Resverlogix Corp.
|
May 11, 2019 07:04AM
|
|
Re: NLRP3 inhibitors and apabetalone
|
6
|
Resverlogix Corp.
|
Jul 26, 2019 01:24PM
|
|
Re: What else can RVX treat that we don’t know about yet?
|
5
|
Resverlogix Corp.
|
Mar 30, 2019 10:16PM
|
|
Re: AHA 2018
|
5
|
Resverlogix Corp.
|
Nov 11, 2018 10:41AM
|
|
Re: Don't look now but...
|
5
|
Resverlogix Corp.
|
May 08, 2019 10:56AM
|
|
Re: Publication / Resverlogix An Author
|
5
|
Resverlogix Corp.
|
Aug 21, 2019 06:18AM
|
|
FOBS
|
5
|
Resverlogix Corp.
|
Jul 27, 2019 11:37PM
|
|
Re: MOA of Apabetalone - only affects sick patients
|
5
|
Resverlogix Corp.
|
Apr 15, 2019 09:42AM
|
|
ALP & Biomarker Signatures
|
5
|
Resverlogix Corp.
|
Jun 13, 2019 01:01PM
|
|
Re: Crestor / Lipitor
|
5
|
Resverlogix Corp.
|
May 02, 2019 09:23PM
|
|
Re: 3 point MACE vs 5 point MACE
|
5
|
Resverlogix Corp.
|
Nov 03, 2018 04:38AM
|
